Indian Government Contacted By Russia To Manufacture Covid Vaccine

Indian Government Contacted By Russia To Manufacture Covid Vaccine

On Tuesday, a government official has said that Russia came in touch with the Indian government for collaboration in the manufacturing of COVID vaccine -Sputnik V

To officially register for the coronavirus vaccine, Russia became the first country to do so. Russia’s President, Vladimir Putin said that one of his daughters was treated with the registered vaccine.

Last week, researchers of Russia informed that the vaccine is currently in its Phase 3 of the clinical trial.

As per a government official, Dr Vinod Paul will be examining the suggestions for potential collaborations on the development of the vaccine. Dr Vinod Paul is the member of the NITI Ayog and is co-chairing the task force of the Vaccine and Research Development. 

With inputs from members and especially the Department of Biotechnology and the ICMR, the committee will be examining the matter’s information and will join the potential collaborators a government official added.

“More than 40,000 people in 45 medical centres are participating in a randomized, double-blind, placebo-controlled multicenter clinical study of the efficacy, immunogenicity, and safety of the Sputnik V vaccine in Russia, simultaneously with the vaccination of volunteers from risk groups,” Russian researchers had said during an online press briefing last week.

As per news reports, CEO of Russian Direct Investment Fund said that they are looking for Indian drug producers to co-partner with them to produce a vaccine which meets the demand.

On August 1, the 1st and 2nd phase of the vaccine was completed. Researchers from Gamaleya National Institute said that all of their volunteers were feeling good and there were no side-effects observed so far. They added that the vaccine produces a strong antibody, thus not even a single volunteer contracted COVID-19 after being injected with the vaccine.

In Russia, more than 2,000 people are involved in the clinical trial of the vaccine’s phase 3. Numbers also include Middle Eastern countries and Latin American countries. 

On August 11, the Russian Ministry of Health provided a registration certificate to the vaccine.


Facebook Comments